LB
MTNB icon

Leo Brokerage’s Matinas BioPharma MTNB Stock Holding History

Leo Brokerage’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$31K Buy
+480
New +$20.7K 0.01% 183

Other funds holding MTNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Courage Capital Management Nashville, Tennessee $70.6M AUM 13.29% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Leo Brokerage's MTNB Position: Q3 2021 in Review

Leo Brokerage opened a new position in Matinas BioPharma (MTNB) in Q3 2021: 480 shares worth $31K. The stake represents 0.01% of the portfolio and ranks #183 among its holdings.

67 funds tracked by Wall St. Rank hold MTNB as of Q3 2021.

  • Leo Brokerage held 480 shares of Matinas BioPharma worth $31K as of Q3 2021.
  • Matinas BioPharma was a new Leo Brokerage position in Q3 2021.
  • Matinas BioPharma made up 0.01% of Leo Brokerage's portfolio in Q3 2021, its #183 holding.
  • 67 funds tracked by Wall St. Rank held Matinas BioPharma as of Q3 2021.

Based on Leo Brokerage's 13F filing for Q3 2021, filed 13 Oct 2021.